122 related articles for article (PubMed ID: 34012514)
1. Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.
Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C
Oncotarget; 2021 May; 12(10):1024-1025. PubMed ID: 34012514
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
4. Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition.
Wei X; Li Q; Li Y; Duan W; Huang C; Zheng X; Sun L; Luo J; Wang D; Zhang S; Xin X; Gao M
Oncotarget; 2022; 13():118-119. PubMed ID: 35035777
[TBL] [Abstract][Full Text] [Related]
5. Correction: Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling.
Peake BF; Eze SM; Yang L; Castellino RC; Nahta R
Oncotarget; 2020 Nov; 11(44):4074-4075. PubMed ID: 33216843
[TBL] [Abstract][Full Text] [Related]
6. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
[TBL] [Abstract][Full Text] [Related]
7. Correction: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression.
Li C; Song L; Zhang Z; Bai XX; Cui MF; Ma LJ
Oncotarget; 2020 Aug; 11(34):3263-3264. PubMed ID: 32922665
[TBL] [Abstract][Full Text] [Related]
8. Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2019 Aug; 10(50):5253. PubMed ID: 31497254
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients.
Markiewicz A; Topa J; Nagel A; Skokowski J; Seroczynska B; Stokowy T; Welnicka-Jaskiewicz M; Zaczek AJ
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634453
[TBL] [Abstract][Full Text] [Related]
11. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
12. Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
Tang B; Qi G; Tang F; Yuan S; Wang Z; Liang X; Li B; Yu S; Liu J; Huang Q; Wei Y; Zhai R; Lei B; Yu H; Jiao X; He S
Oncotarget; 2020 May; 11(19):1797-1798. PubMed ID: 32477467
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
Almozyan S; Colak D; Mansour F; Alaiya A; Al-Harazi O; Qattan A; Al-Mohanna F; Al-Alwan M; Ghebeh H
Int J Cancer; 2017 Oct; 141(7):1402-1412. PubMed ID: 28614911
[TBL] [Abstract][Full Text] [Related]
14. Correction: PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway.
Tang D; Zhang J; Yuan Z; Zhang H; Chong Y; Huang Y; Wang J; Xiong Q; Wang S; Wu Q; Tian Y; Lu Y; Ge X; Shen W; Wang D
Oncotarget; 2021 Sep; 12(20):2111-2113. PubMed ID: 34611485
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
16. Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
Oncotarget; 2020 Feb; 11(8):825-826. PubMed ID: 32166003
[TBL] [Abstract][Full Text] [Related]
17. Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients.
Markiewicz A; Nagel A; Szade J; Majewska H; Skokowski J; Seroczynska B; Stokowy T; Welnicka-Jaskiewicz M; Zaczek AJ
Transl Oncol; 2018 Jun; 11(3):722-731. PubMed ID: 29660692
[TBL] [Abstract][Full Text] [Related]
18. Correction: Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2019 Oct; 10(56):5888. PubMed ID: 31645907
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
20. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.
Sun C; Sun L; Jiang K; Gao DM; Kang XN; Wang C; Zhang S; Huang S; Qin X; Li Y; Liu YK
Int J Biochem Cell Biol; 2013 Jun; 45(6):1099-108. PubMed ID: 23474366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
